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Arachidonic acid (AA), the precursor of prostaglandins and 
leukotrienes, can be directly liberated from membrane 
phospholipids by phospholipase A2 or indirectly by phos-
pholipase C. One or both of these enzy mes may be re-
sponsible for the in creased content of AA found in psoriatic 
les ional epidermis . K eratome biopsies were obtai ned from 
normal and psoriatic individuals. After homogenization and 
sonication , a 10,000 g supern ata nt was used as the enzy me 
source. The activities of both phospholipase A2 and C were 
assayed in each samp le usin g phosphatid ylcholine and 
phosphatidylinositol, respectively, as substrates. Phospho-
lipase A2 activity w as found to be signifi cantly higher than 
normal in both uninvol ved and lesional psoriatic epidermis. 
In contrast, phospholipase C activity was signifi cantly higher 
than normal in on ly the psoriatic plaque on the basis of 
A rachidonic acid (AA) is th e pr.ecurso r of a fam il y of inflammato ry and mitogeni c m ediators known col-lectIvely as clcosanolds. These elcosa no ids, as well as free AA are found in high concentrations in pso-riati c lesions [1 -4] and are thou ght to playa role in 
the pathogenesis of the disease. 
The rate-limiting step in the sy nthesis of eicosanoids is generall y 
accepted to be the availability o f free AA [5]. This fatty acid is 
esterifi ed in the 2 position of phospholipids and its release is 
induced by a receptor-mediated ac ti va tion of phos pholipase A2 
[6-10] . The act ivity of phospholipase A2 has been reported to be 
higher than norma l in psoriatic ep idermis, in parti cular, the lesion-
free epidermis [11-13]. The auth o rs have pos tulated that thi s 
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Abbreviations: 
AA: arachido ni c acid 
DG: diacylg lyce rol 
2-M G: 1l10noacylg lycero l 
PA: phosphatidic acid 
PC: phosphatidylcho linc 
PE: phos phatid ylethanolamine 
PI: phosphatid ylinositol 
wet weight (p < 0.001), protein (p = 0.01), and DNA 
(p = 0.004) content . Phospholipase C activity in pmol 
dia cylglycerol form ed/ min / ,ug DNA was : normal 4.96 ± 
0.80, n = 13; unin volved 7.29 ± 1. 06, n = 18; plaq ue 
14.44 ± 2.50, n = ] 8. Analysis (pH profile , calcium re-
quirem ent, substrate specifi city, and sa turation kinetics) of 
pooled epidermal extracts showed no inherent differences 
in phospholipase C from no rm al and psoriati c epidermis, 
sugges ting eith er a hi gher concentration or the presence of 
an activated form of the enzyme in psoriati c pl aq ue. Since 
phospholipase C activity , in contras t to phospholipase A2 
activity, is eleva ted only in les ional epid ermis, it is possibl e 
that this enzy me contribu tes to AA accumulation observed 
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increase in phospholipase A2 acti vity is responsible fo r the elevated 
levels o f ei cosa no ids fou nd in psori atic lesions [11 ,12]. 
H owever , a second pathwa y for AA release throu gh phospha-
tid ylin os itol (PI)-speci fi c ph os ph olipilse C has been reported in 
tissues o th er th an epidermi s [14-1 6]. Phospholipase C hyd rol yzes 
PI formin g inos itol phosphate and d iacy lg lycerol (DG) . Subse-
qu ent metabolism of DG res ulting in AA release ca n occur by 
two pathways: (1) seql1 elltial hydro lysis by DG lipase and mon-
oacy lglyceride lipase fo rming 1110noacylglycerol (2-MG) and AA , 
res pectively /1 4, 171; or (2) initial conversion to phos phatidic acid 
(PA) by DG kin ase fo ll owed by release of AA by a PA-specifi c 
phospholipase A2 [1 8]. 
In this repo rt , a PI-speci fi c phospholipase C in human epidermis 
is described. Since this enzy me is ac ti ve in epiderm is and may 
contr ibu te to the accumulation of AA seen in pso riati c plaque , 
the act ivity of phospholipase C in no rmal , pso ri at ic unin volved , 
and les ional epiderI11is w as characterized. 
MATERIALS AND METH ODS 
Chemicals and Supplies Standard chemica ls and supplies were 
obtained from the foll owing commercial suppliers: aprotinin, AA, 
'1, 2-diolein , bovine li ver phosphatid ylcholine (PC), bovine li ver 
phosphatidylethanolamine (PE) , soy bea n trypsin inhibito r, soy-
bean PI , phospholipase C fr0111 C pelji';lIgell s, and silicic acid 325 
mesh (Sigma C hemical Compan y, St. Louis, Missouri); L-3-PC, 
I-stea royl-2-[5,6,8, 9, 11 ,12, 14, 15-3H]arachidonyl and L-3-PE, 1-
acy l-2-/1-14qarachidon yl and L-3-PI, 'l-stearoyl-2-[1 JICJa ra-
chidonyl (Amersham Corporation, Arlin gton Heigh ts, Illinois); 
Si li ca G thin-laye r chrom atog raph y plates (A naltech In c, N ewa rk , 
Delaware). 
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Tissue Preparation Kerato me biopsies (2 x 4 cm , no rm al an d 
pso riat ic unin vo lved 0. 1-0.2 mm ; pso riatic plaque 0.2- 0.4 mm 
thickn ess) were obta ined fro m norm al (n = 13) and psoriati c (n 
= 18) volun teers using 1 % lidoca ine as an anesth eti c. The patients 
had seve re, sta ble pl aq ue pso ri as is. T he biopsies were rem oved 
at approx im ate ly th e sa me time o f day and fro m the sa me body 
area (lowe r trunk) fro m the pso ri ati c patients and the normal 
volunteers. Fo r the meas urement o f phos pholipase A2 and phos-
pho li pase C ac ti viti es, paired sa mpl es o f unin vo lved (a t leas t 10 
CIll fro m any visibl e plJ que) and pl aqu e pso ri as is we re ta ken fro l11. 
each ind ividual. 
T he tiss ue was immedi ately was hed 2-3 times in ste ril e phos-
phate-buffe red sa line to remove as mu ch res idual blood and lid-
oca ine as possible. After we ighin g, the epiderm al strips were 
ho mogeni zed w ith a Po lyt ron ti ssue g rin de r in 0.5 ml l1 00 mg 
ti ssue of bu ffe red sucrose (0.25 M sucrose, 10 111M T ris-HCl, pH 
7.0, 2 m M EDTA, 100 J.L g/ ml apro tinin , 0.5 m g/ l11l soy bean 
tryps in inhibito r). T he homogenate was centri fuged at 1,000 g, 
20 mi n at 4°C. T he supernata n t was kept on ice and the pell et 
was resus pended in an additional 0.5 m1/1 00 mg ti ss ue-buffered 
sucrose. T hi s suspension was soni ca ted w ith a cell di srupte r probe 
(10-12 1-s bursts, 50 W). After centrifu ga tion (1,000g, 20 min ), 
the supernatan ts were co mbined and centrifu ged at 10,000 ,~, 10 
min at 4°C. T he res ul ting supern atant w as used as an enzy me 
so urce fo r both phospholipase assays. 
Phospholipase C Assay T he substrate was prepared just prio r 
to each experim ent by combinin g 44 J.Lg bov ine brain PI and 1 
X 105 dp m 1-st.caroy l, 2-/1-14C]a rachid onyl PI per sa mple and 
evapo rating the solvent un de r a ni trogen j ct . T he rcs idue was 
resuspended by vo rtexin g in 50 /LI of250 J.Lg/ ml taurodeoxycho-
late and soni cated in a bath soni cato r for 5 min . Phospholipase 
C activ ity was assayed using a modifi ca tion of the procedure 
described by C hau and Tai [1 9]. In a fin al vo lulll e o f 0 .5 ml , th e 
in cubation mixture contai ned: 20 m M T ris-H C I, pH 7.0, 1 mM 
CaCh, and 100 J.L M PI. The reacti on was sta rted by th e add ition 
of the ep idcrm al ex tract (30-40 J.L g protein ). After 30 min at 3rC, 
th e reaction was te rmin ated by th e additi on of 50 J.LI 1 M HC I. 
T hc lipid produ cts, as well as 10 J.L g ca rri er 1,2 di olein , we re 
extracted with 1.5 ml benzene (grea ter than 90% of th e unreacted 
PI remaincd in the aq ueo us ph ase). An aliquot (1 ml ) o f th e orga ni c 
phase was eva porated under nitrogen and spo tted onto Sili ca C 
thin-layer chromatograph y plates. T he pla tes werc developed w ith 
heptanc:iso propy l eth er:acetic acid (60:40:4 vo l: vol:vol). Lipids 
werc visualizcd w ith 12 va por and th e radi oactive produ cts vi-
sualized by au to radiog raph y. Id cnti fica ti on of DC was based on 
comigra tion w ith 1,2-d io lein and was verifi ed using purifi cd 
phos pholipase C fro m C perjringcns to gcncrate 1-stea roy l-2-[1-
l'IC]arachidonyl DC fro m [I.IC]PI. The areas co rres pondin g to 
DC werc scra ped in to scintillation vials and the radioactivity eluted 
fro m the sili ca with 0 .5 ml methano l. After the additi on of "10 ml 
Safety So lve scintill ati on cock tail , th e radi oactivity in DC was 
quantitated by scin till ati on spectro metry. 
Properties of Epidermal Phospholipase C Fo r thcsc studies , 
add itional biops ies wcre obtained (10 no rm al, 13 uninvolvcd, and 
11 pla que). T he biopsies were proccssed separately on th e da y 
they were obtained and phospholipasc C acti vity was qu antitated 
in each sample befo re they wcre pooled . T he enzy me prcparations 
remained stablc throughout th e co ursc of th e ex periments. T hc 
linca ri ty of the assay, pH optimum , mctal ion requi rc ments, and 
the substratc specifi city and sa turati on kin eti cs were determin ed 
using these enzy me prepara tions. 
To dete rmine the linea rity of the assay, an aliquo t o f no rm al 
epidermal extrac t was in cubated fo r 15, 3D, 60, 90, and 120 min . 
T he am ount of DG and 2-MC was determin ed. 
To determine the pH profil e of phospholi pase C in no rm al and 
pso ri atic epiderm is, th e assay was run fo r 30 l11in usin g T ris-HC I 
react ion bu ffer th at had been adju sted to a pH rang ing fro m 
4.5-8.5, va rying at in terva ls of 0.5 . 
To determ ine the meta] ion req uiremcnts of this enzy me the 
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assay was run fo r 30 min at a ca lcium concentration ra ng ing from 
0.0-2.5 mM. Mg + + and Mn "'''' at equivalen t concentrations were 
also tested. 
For substrate specificity assays, rJH] PC and [1 4C]PE were pre-
pared w ith un labeled PC and PE, respectively, as described for 
PI (44 J.L g phospho lipid plus 1 X 105 dpm 14C-labelcd phospho-
lipid). T hese were tes ted as substrates in th e phos pholipase C 
assay usin g th e 3 epiderm al ex trac ts. 
T he sa turati on kineti cs o f phos pholipase C from normal and 
pso riatic invo lvcd and les ional epidermis were done using PI con-
centrations rangin g from 0-60 J.LM . T he assay was run fo r 30 min . 
Phospholipase A2 Assay Phospholipase A2 acti vity was qu an-
tita tcd usin g a modifi ca ti on of the procedurc described el sewhere 
[11] . T he substrate was prepared as described above fo r phos-
pho lipasc C, however, bo vine liver PC (40 /Lg) and 1-stea royl-
2-rJI-:I] arachid onyl PC (2 X 105 dpm) were used instead of PI. 
T he incubati on mi x ture, in a fin al volulll e o f 0.5 ml , contained : 
100 111 M g lycine/ N aO H (pH 8.5) , 1 111 M C aCh , and 100 /LM Pc. 
After the additi on of epiderm al ex tra ct (100-150 J.Lg protein), the 
sa mples w ere incubated at 3rC fo r 60 min . The reaction was 
stoppcd by th e addition of 0.5 ml 0.5 M fo rmi c acid . The lipids 
we re extrac ted w ith 1 mlmethan o l and 2 1111 isopropyleth er, after 
th e additi on of 10 J.L g AA . The unreacted PC w as removed by 
sili cic acid adso rpti on as described by Smith and Silver [20]. T he 
produ ct of the reaction, [JH]AA, remaining in the supern atant 
was qu antitated in a 1-ml aliquo t by scil)tiJlation counting . 
Protein and DNA Assays Protein concentrati on in the extracts 
was determin ed acco rdin g to th e procedure of Lowry et al [21]. 
DNA contcnt w as quantitated in the initial pellet of tissue using 
diph cnylamine reagent, as describcd elsewhere [22J. 
Statistical Analysis Fo r bo th ph os pholipase C and phos pho-
lipase A2 acti vities, th e data wc re analyzed using Studcnt's I-test 
for unpaircd (n o rm al vs unin volved, no rm al vs plaque) o r paired 
(uninvo lved vs plague) data w ith a 2-tailed hypothesis. 
RE SULTS 
Phospholipase C and Phospholipase A 2 Activities in Normal 
and Psoriatic Epidermis Phospholipase C, quantitated as the 
hydrol ysis o f PI to D G, w as assayed in extrac ts fro m normal, 
pso riati c unin volved, and lesiona l cpidermi s. Fo r aU 3 tissues, 
g rea ter th an 90'},0 o f th e activit y waS retained in a 10,000 g su-
perna ta nt (data no t shown) . The phos pholipase C acti vity in these 
preparations was stabl e fo r at leas t 6 months when stored at 
- 20°C. However, the most consistent results were observcd when 
freshly obta incd ti ssue was used instead of frozen biopsies. T he 
presence of residual b lood and lidoca ine in snap-frozcn biopsies 
was found to intcrfere w ith th e enzy me assays. 
T able I shows th e acti vity o f phos pholipasc C in no rm al and 
pso ri ati c skin. The enzy m e activ ity was signifi cantl y higher in 
plaqu e w hen comparcd w ith no rm al o r uninvolved psorias is. This 
di ffercncc was statist ica ll y signifi ca nt (p < 0.05) on all 3 data bases 
exa mined (i. e., mg pro tein, mg wet weight, J.L g DNA) . In con-
tras t , th e activity in unin volved skin was not statisti ca lly hi gher 
than no rm al fo r any o f th e data bases 0) > 0.05). 
As a comparison fo r phos pholipase C activity, phos pholipase 
A2 activity was assayed in th c sa mc sa mples. In ag rec ment with 
prev ious reports [1 '\ , '13], phospholipase A2 activity w as el evated 
in psori ati c cpidcrmis, particul arly in the uninvolved skin (T able 
II ). It is interestin g to no te, howcvcr, th at phos pho lipase C ac-
ti vity, w hi ch is 3-7 tim cs g reater th an that o f phos pholipase A2, 
is hi gher than normal onl y in the psoriati c lesions. 
T o detcrmin e wheth er th e in creased activity of phos pholipase 
C in pso ri ati c plaque was due to altered propcrti es o f the enzyme 
in pso ri atic epidermis, th e enzy m e acti vity was pa rti all y charac-
terized in all 3 tissucs. 
Linearity of the Assay Conditions The formation ofDG from 
PI was linea rl y rel ated to pro tein concentration up to 100 /Lg 
pro tcin (data not sho wn) . T he reaction w as no t Iinca r with more 
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Table I. Phospholipase C Activity in Normal and 
Psoriatic Epidermis 
pmol Diacylglycerol (DG) Formedlminl 
mg Protein mg Wet Weight ILg DNA 
Normal (n = 13) 1097 ± 113 8.03 ± 1.02 4.96 ± 0.80 
Uninvolved (n = 18) 1114 ± 117 8.39 ± 0.93 7.29 ± 1.06 
Plaque (n = 18) 1684 ± 160 18.03 ± 1.02 14.44 ± 2.50 
Uninvolved vs 2% 4% 47% 
normal (p = 0.91)" (p = 0.80) (p = 0.11) 
Plaque vs normal 54% 125% 191 % 
(p = 0.01) (p < 0.001) (p = 0.004) 
Plaque vs uninvolved 51% 115% 98% 
(p < 0.001) (p < 0.001) (p = 0.002) 
Phospholipase C activity, quantitated as the formation of DG from phosphati-
dylinositol, was determined as described in Materia{s alld Met{,ods. The difference 
between th e activity in norma l and unin vo lved ep idermis was not statistica ll y sig-
nifi cant for any of the data bases . 
' Student's I-test for unpaired (uninvolved vs normal , plaque vs normal) and paired 
(plaque vs uninvolved) data, two-tailed hypothesis. 
than 100 /Lg protein, particularly in the plaque prepara tion, due 
to depletion of the substrate. The concentration of DG was seen 
to increase with time over a 30-min incubation period. However, 
longer incubations resulted in furth er metabolism of DG to 2-
MG (Fig 1). 
pH Optimum All 3 enzymes exhibited optimal activity at pH 
7.0 (Fig 2). Little enzyme activity could be detected below pH 
4.0 or above 9.0. 
Effect of Metal Ions Epidermal phospholipase C has an ab-
solute requirement for calcium ions (Fig 3). Due to the presence 
of EDT A in the homogenizing buffer, no activity w as detected 
in the samples w ithout the addition of exogenous calcium. Max-
imal enzyme activity was seen at 1 111M CaCho At concentrations 
above 5 mM, however, CaCh was inhibitory (30% inhibition at 
10 mM CaCh). Other metal ions, Mg + + and Mn ++ , did not 
substitute for calcium in activating phospholipase C (data not 
shown). 
Substrate Specificity The 3 major phospholipids , PC, PE, and 
PI, were tested as substrates for epidermal phospholipase C. The 
results in Table III show that PI is the preferential substrate for 
normal, uninvolved, and plaque enzymes. The PC and PE are 
also hydrolyzed but at a rate less than 2% of that for PI. 
Substrate Saturation Kinetics The effect of substrate concen-
tration on the rate of hydrolysis is shown in Fig 4. The saturation 
curve showed a biphasic pattern. The first plateau was reached 
at 40 /LM for all 3 enzymes. Above 100 /LM , the phospholipase C 
activity rapidly increased with increasing PI concentration (data 
Table II. Phospholipase A2 Activity in Normal and 
Psoriatic Epidermis 
mg Protein mg Wet Weight ILg DNA 
Normal (n = 13) 188 ± 34 0.54 ± 0.18 0.85 ± 0.1 2 
Uninvolved (n = 16) 379 ± 42 2.63 ± 0.16 2.30 ± 0.25 
Plaque (n = 16) 242 ± 29 2.07 ± 0.11 1.63 ± 0.19 
Uninvolved vi; 102% 387% 171 % 
normal (p = 0.002)" (p < 0.001) (p < 0.001) 
Plaque vs normal 29% 283% 92% 
(p = 0.24) (p < 0.001) (p = 0.003) 
Uninvolved vs plaque 57% 27% 41% 
(p = 0.002) (p = 0.006) (p < 0.001) 
Phospho lipase A, activity was quantitated as formation of arachidonic acid from 
phosphatidylcholine as described in Matcr;,,{s alld Met{,ods. 
"S tudent 's (-tcst for ullpaired (uninvolved vs n01"ma l, plaque vs normal) and paired 
(uninvolved vs plaque) data , two-tail ed hypothesis. 
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Figure 1. Metabolism of PI to DG (so lid circles) and 2-MG (opel/ circles) 
in human normal epidermis. One hundred and fifty micrograms protein 
of epidermal extract was incubated for the indicated times with [14C]pl. 
The lipids were extracted and analyzed by thin-layer chromatography as 
described for phospholipase C assay in Ma terials mId Methods . 
not shown). This phenomenon has previously been reported for 
purified phospholipase C from human platelets and is due to 
micel lar formation of the substrate [23] . 
DISCUSSION 
In psoriatic lesions, the quantity of free AA and the lipoxygenase 
product 12-HETE are significantly elevated when compared wi th 
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Figure 2. The pH profile of phospholipase C activity in normal and 
psoriatic epidermis. The activity of phospholipase C was determined using 
100 mM Tris adjusted to the indicated pH. Normal, solid circles; unin-
volved, ope" circles; plaque, opel/ trial/gles . 
450 BARTEL, MAI1CELO, AND VOORHEES 
7 
Z 
W6 
b 8:5 
(!) 
~4 
Z 
~:3 
(!) 
o 
en 2 
W 
...J 
o 
~ 
z 
1.0 1.5 2.0 2.5 0.5 
CALCIUM CONCENTRATION (mM) 
Figure 3. Effect of calcium ions of phospholi pase C act ivity in normal 
and psoriat ic epiderm is. Norm al, solid circles; unin volved, open circles; 
plaque, ope/l t rin ll,~ /fS . 
the no rm al and un invo lved psoriati c epidermis [1,2]. T he levels 
of lcukotri enes (L T), most no tab ly L TB", and of the cyclooxy-
genase pro ducts prosta g landin (PG) E2 and F2a are also elevated 
in the lesio nal tissue [1 -4'\. T he exact cause o f this accumulatio n 
of free AA and its transformation pro du cts in the les ion is unclea r. 
Two phospholipases are primarily responsible for th e release 
of AA from m embra ne phos pholipids. Phospholipase A2 directl y 
liberates AA from phospholi pids, m ost notably Pc. Thus, an 
activat ion of phospholipase A2 in the lesional epidermis cou ld 
exp lain the accumulated free AA and m eta bolites. However, pre-
v ious reports that were confirmed in this study have demon-
strated that the activity of this enzy me is hig hest in psoriati c 
unin volved epidermis when compared with normal epidermis 
[11 - 13]. M oreover, Forster et al reported an eleva ted phospho-
li pase A2 ac tivity in psoriatic lesional tissue that was not statis-
tica ll y different from the no rmal va lue. They expressed epidermal 
phospho li pase A2 activity as per m g of protein [11]. 
In the present study a statisticall y significant increase in lcsional 
phospholipase A2 activity was dem onstrated when the data were 
expressed per total DNA and per m g w et weight, but not w hen 
the data base was m g of pro tein . Thus our observations agree 
w ith those reported b y Forster et al. We add itio nall y report sig-
nifi can tl y elevated enzy m e activity in th e les iona l epidermis wh en 
compared w ith norm al ti ss ue usin g the DNA and wet weight 
data bases. T he enzy m e acti vity in o ur studi es was 3- to 5-fold 
g reater than repo rted by Forster et al [11] . T his inconsistency 
probab ly refl ects a difference in technique. O ur studies used the 
Table III. Substrate Specificity of Epidermal 
Phosp ho lipase C 
Substrate 
Normal 
Uninvolved 
Plaque 
Phosphatid yl- Ph osphatid yl- Phosphatid yl-
choline ethanolamine inositol 
(pmol diacylglycerol for med/min/ mg protein) 
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Figure 4. Effect of PI concentration on phospholipase C in norm al and 
psoriatic epidermis. Norm al, solid circles; unin volved, OpC/l circles; plaque, 
opell triollgles. 
1,000 g supernatant of sonica ted epiderm al ho mogenates to assay 
fo r phospho lipase A2 activity . Forester et al used the homogenate 
itself as the enzy me source. T hi s wo uld res ult in a larger total 
pro tein data base, hence th e lower enzyme activity v:liues . 
T hus o ur studi es and those of other investigato rs indi cate that 
phospho lipase A2 activity is highest in uninvolved psoriatic epi-
derm is [11-1 3]. Our data also showed that phospho lipase Az 
ac tivity is signifi ca ntly elevated in lesio nal epidermis when co m-
pared with no rmal epiderm is, and is sign ifi ca ntly lower than the 
activity of uninvolved epidermis. T hese res ults suggest that whereas 
phospho lipase A2 act ivity ma y, in part , be res ponsible for the 
increased AA levels seen in psoriati c les ions, other additional 
m echanisms are m os t probabl y invol ved. 
The first step in an altern ative pathway for the release of AA 
is the h ydrolysis of PI , fo rmin g DG and inos itol phosphate(s) b y 
phos pho li pase C. In subsequent enzymatic tran sform ations , DG 
ca n be metabolized to fo rm free AA. An increase in th e activity 
o f this pathway in the epidermis could result in an increased 
amount of AA and eicosano ids. 
T he results presented in thi s report demonstrate the presence 
of phos pholi pase C activity in human epidermis and show that 
this activity is elevated over norma l and uninvolved pso rias is in 
th e psoriatic les ional plaque. Epidermal phospholipase C has a 
pH optimum of 7.0, and absolute requirement for ca lcium ions 
and a marked specifi city for PI. T his is cO J1 sistent with the prop-
erti es of phospholipase C in other ti ssues [24-26]. 
N o g ross differen ces in th e param eters exa mined were observed 
between the no rmal, uninvolved, and lesional enzy mes to account 
for the increased activity in the pl aq ue tissue. This suggests that 
lesional phospholipase C is not a different phos pholipase enzy me, 
but rather, that either a hig her concentration o r an activated fo rm 
of this enzy l Ie exists in the plaque tissue. Further stud ies with a 
m o re purifi ed preparation arc needed to determine the precise 
cause o f elevated phospho lipase C activity in lesiona l psoriatic 
epidermis. 
It is no t known w hether th e eleva ted phospholipase C ac tivity 
in psoriatic lesional epidermis is contributing to th e accumu lation 
of AA seen in this tissue. T he m atter is furth er co nfused b y the 
observation that glucocorticoids, whi ch are therapeuti c in pso-
ri as is, inhibit phospholipase A2 act ivity [1 3]. The subsequent m e-
tabolism o f DG to 2-M G, the second enzymatic step in the phos-
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pholipase C -dependent pathway for AA release, occurs in the 
epidermis. This sugges ts that the enzy mes invo lved in this alter-
nate pathway may be present and active in human epidermis. 
O bviously, furth er studies on the contribution of the PI-phos-
pholipase C pathway to the free AA pool seen in pso riatic epi-
dermis are necessa ry. 
Potentially most important to the understandin g of the patho-
logic m echanism seen in psorias is is th e fact that the activation 
of the PI-specific phospholipase C could have a profound effect 
on th e physio logy of the epidermis. Both products of th e enzy me 
reaction, DG and the inos ito l phos phate(s), have been implica ted 
as a part of a signal transduction mechanism. The triggering of 
these events in a number of tiss ues controls a va ri ety of cellular 
processes throu gh acti vation of a li pid- and ca lcium-sensiti ve pro-
tein kinase C, and by the mobili zat ion of intracellular calcium 
stores [26]. Included among these processes is cell proliferation 
an d differentiation, both of which are abnorm al in the psoriatic 
epidermal keratinocyte [27] . 
Activation of epiderm al phospholipase C may be shown in 
future studies to con trol epiderm al cell function by havin g a dual 
effect, both on epidermal AA metabo lism and on processes more 
directly influencing the ph ysio logy of the cell. Thus, phospho-
lipase C ma y prove to be an important target for therapeuti c 
agents designed to be effective in the treatment of the skin disease 
psorias is. 
Ti,e allthors wish (a thnl"~ Dr. Villce Z iboh, DOl/is, Califo ,."iafor II/nll)' didactic 
diswssiolls ill the area of arachidollic acid /II etabo lis/ll. 
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